References
1. Alfishawy M., Elbendary A., Mohamed M., Nas-sar M. COVID-19 mortality in transplant recipients. Int J Organ Transplant Med. 2020; 11 (4): 145-62.
2. Parabina E., Konstantinov D., Kaabak M., Rappoport N., Pushkin S., Selyutin A., et al. COVID-19 vaccination issues in solid organ transplant recipients. Vestnik meditsinskogo instituta «REAVIZ» [Bulletin of the Medical Institute «REAVIZ»]. 2021; (4). DOI: https://doi.org/10.20340/vmirvz.2021.4.COVID.2 (in Russian)
3. Kamar N., Abravanel F., Marion O., Couat C., Izopet J., Del Bello A. Three doses of an mRNA COVID-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021. DOI: https://doi.org/10.1056/nejmc2108861
4. Basic-Jukic N., Jelicic I. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis. 2021; 2021: e13628.
5. Tsalouchos A., Rossolini G.M., Magg L., Maz-zoni A., Annunziato F., Dattolo P.C. COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination. Transpl Infect Dis. 2021; 2021: e13649.
6. Tau N., Yahav D., Schneider S., Rozen-Zvi B., Abu Sneineh M., Rahamimov R. Severe consequences of CO-VID-19 infection among vaccinated kidney transplant recipients. Am J Transplant. 2021; 21 (8): 2910-2.
7. CDC Director Rochelle Walensky Talks Boosters, Masks and Health Equity. Home - Community Health Center Presents Conversations on Health Care. URL: https:// www.chcradio.com/episode/Rochelle-Walensky/579
8. U.S. Department of Health and Human Services. (2021, June 1). NIH clinical trial evaluating mixed CO-VID-19 vaccine schedules begins. National Institutes of Health. URL: https://www.nih.gov/news-events/newsre-leases/nih-clinical-trial-evaluating-mixed-covid-19-vac-cine-schedules-begins
9. Kaabak M.M., Maschan A.A., Babenko N.N., Zokoev A.K., Cheprasova T.Yu., Belyaeva L.E., et al. Blockade of costimulation with Campas administered 2-3 weeks before kidney transplantation from a living donor. Is it possible to develop donor-specific tolerance with this type of induction of immunosuppression? Vestnik transplanto-logii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs]. 2008; (3): 7-12. (in Russian)
10. Kaabak M.M., Babenko N.N., Zokoev A.K., Schekaturov S.V., Shapiro R., Maschan A.A., et al. Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction. Pediatr Transplant. 2017; 21 (5): 12941. DOI: https://doi.org/10.1111/petr.12941
11. Bikbov B.T., Tomilina N.A. Replacement therapy of end-stage chronic renal failure in the Russian Federation in 1998-2013. Nefrologiya i dializ [Nephrology and Dialysis]. 2015; 17 (3 Suppl): 5-111. (in Russian)
12. Bikbov B.T., Tomilina N.A. Composition of patients and quality indicators of treatment for replacement therapy of end-stage chronic renal failure in the Russian Federation in 1998-2013. Nefrologiya i dializ [Nephrology and Dialysis]. 2016; 18 (2): 98-164. (in Russian)
13. Tomilina N.A., Andrusev A.M., Peregudova N.G., Shinkarev M.B. Renal replacement therapy for end-stage chronic renal failure in the Russian Federation in 2010-2015. Nefrologiya i dializ [Nephrology and Dialysis]. 2017; 19 (4). DOI: https://doi.org/10.28996/1680-4422-2017-4-1-95 (in Russian)
14. Gautier S.V., Khomyakov S.M. Organ donation and transplantation in the Russian Federation in 2017. X message from the register of the Russian Transplant Society. Vestnik transplantologii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs]. 2018; 20 (2): 6-28. DOI: https://doi.org/10.15825/1995-1191-2018-2-6-28 (in Russian)
15. Kaabak M.M., Rappoport N.N., Bryzgalina E.V., Fisenko A.P., D’yakonova E.Yu., Rybalko A.S. Transplant Register. Vestnik transplantologii i iskusstvennykh organov [Bulletin of Transplantology and Artificial Organs]. 2020; 22 (S): 20. (in Russian)
16. Special Considerations in Solid Organ Transplant, Hematopoietic Stem Cell Transplant, and Cellular Immunotherapy Candidates, Donors, and Recipients. Last Updated: October 19, 2021.
17. URL: https://www.covid19treatmentguidelines.nih.gov/special-populations/transplant/
18. URL: https://www.covid19treatmentguidelines.nih.gov/therapies/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies/